(Q46170786)

20 December 2017

title

The vascular and biochemical effects of cilostazol in diabetic patients with peripheral arterial disease (English)

1 reference

20 December 2017

author

Ian S. Young

5

1 reference

20 December 2017

author name string

Mark E O'Donnell

1

1 reference

20 December 2017

Stephen A Badger

2

1 reference

20 December 2017

Muhammad A Sharif

3

1 reference

20 December 2017

Ragai R Makar

4

1 reference

20 December 2017

Bernard Lee

6

1 reference

20 December 2017

C V Soong

7

1 reference

20 December 2017

publication date

8 January 2009

1 reference

20 December 2017

Vascular and Endovascular Surgery

published in

1 reference

20 December 2017

volume

43

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

132-143

1 reference

20 December 2017

Intermittent claudication. A risk profile from The Framingham Heart Study.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

The course of peripheral vascular disease in non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Aging, habitual exercise, and dynamic arterial compliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

The pharmacology of cilostazol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Effects of cilostazol on resting ankle pressures and exercise-induced ischemia in patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

The effect of cilostazol on glucose tolerance and insulin resistance in a rat model of non-insulin dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Cilostazol, a phosphodiesterase inhibitor, improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a model of spontaneous NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Use of arterial transfer functions for the derivation of central aortic waveform characteristics in subjects with type 2 diabetes and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Peripheral "oscillatory" compliance is associated with aortic augmentation index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Treating peripheral arterial disease in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Cilostazol treatment of claudication in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Endothelial dysfunction: does it matter? Is it reversible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Vascular compliance and cardiovascular disease: a risk factor or a marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Effects of cilostazol on serum lipid concentrations and plasma fatty acid composition in type 2 diabetic patients with peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Cilostazol reduces inflammatory burden and oxidative stress in hypertensive type 2 diabetes mellitus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Cilostazol: a review of its use in intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574408328586

21 January 2018

Identifiers

DOI

10.1177/1538574408328586

1 reference

20 December 2017

1 reference

20 December 2017